NCT02479217View on ClinicalTrials.gov

Safety of Xeloda in Solid Tumours

CompletedOBSERVATIONAL

Enrollment

1,268

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Metastatic Breast Cancer, Colon Cancer

Interventions

DRUG

Docetaxel

DRUG

Xeloda

Trial Locations (1)

21204

Kamenitz

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02479217 - Safety of Xeloda in Solid Tumours | Biotech Hunter | Biotech Hunter